# BridgeBio Inc.

BridgeBio Inc. is a Genetic Disease Therapeutics based in London, United Kingdom.

## Overview

- **Organization type:** Genetic Disease Therapeutics
- **Headquarters:** London, United Kingdom
- **Region:** Europe
- **Address:** London, United Kingdom
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** https://bridgebio.com
- **LinkedIn:** https://www.linkedin.com/company/bridgebio

## Regulatory record

- **Reports private funds:** No

## About

BridgeBio Inc. was established with an investment mandate centered on biotechnology and pharmaceutical innovation, though its founding year and principals have not been publicly detailed. The firm's name echoes the well-known publicly traded biotech company BridgeBio Pharma, but the two entities are distinct, and no direct affiliation has been confirmed. The firm allocates capital across biotech startups, clinical-stage therapeutics, and healthcare services, focusing on early- to mid-stage opportunities. Its geographic spread—London, Boca Raton, Palo Alto, New York, and Boston—covers key biotech hubs in the US and Europe. No specific portfolio companies or co-investors have been publicly identified. Total AUM and team size remain undisclosed. No adjacent philanthropic or operating vehicles have been identified in public sources. BridgeBio Inc.'s structural differentiator is its international biotech focus combined with a multi-hub operational model, a configuration uncommon among pure healthcare asset managers. The lack of public information on leadership or strategy limits further assessment.

## Sectors

- Biotech
- Pharmaceuticals
- Healthcare Services

## Offices

- Boca Raton
- Palo Alto
- New York
- Boston

## Questions

### Who runs investment decisions at BridgeBio Inc.?

BridgeBio Inc. has not publicly named its investment decision-makers, making it unclear who holds roles such as CEO or CIO. The firm's leadership structure is opaque, and no public filings or press releases have identified key individuals.

### Is BridgeBio Inc. related to BridgeBio Pharma?

BridgeBio Inc. shares a name with the Nasdaq-listed BridgeBio Pharma, but there is no public evidence of a direct structural or ownership link. The two entities appear distinct, and BridgeBio Inc. does not mention any affiliation in available sources.

## Related profiles

- [10X Genomics](https://altss.com/profile/10x-genomics)
- [Select Rehabilitation](https://altss.com/profile/select-rehabilitation)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/bridgebio-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology